- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2051-1426
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Targeting tumor-necrosis factor receptor pathways for tumor immunotherapy ; volume:2 ; number:1 ; day:15 ; month:4 ; year:2014 ; pages:1-9 ; date:12.2014
Journal for ImmunoTherapy of Cancer ; 2, Heft 1 (15.4.2014), 1-9, 12.2014
- Urheber
-
Schaer, David A.
- Beteiligte Personen und Organisationen
-
Hirschhorn-Cymerman, Daniel
Wolchok, Jedd D.
SpringerLink (Online service)
- DOI
-
10.1186/2051-1426-2-7
- URN
-
urn:nbn:de:1111-2016072656163
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:54 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Schaer, David A.
- Hirschhorn-Cymerman, Daniel
- Wolchok, Jedd D.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Toward integrative cancer immunotherapy: targeting the tumor microenvironment
Targeting PCSK9 to upregulate MHC-II on the surface of tumor cells in tumor immunotherapy
Targeting the macrophage immunocheckpoint: a novel insight into solid tumor immunotherapy
Emerging strategies in targeting tumor-resident myeloid cells for cancer immunotherapy
Nanomedicine Tumor Targeting
Nanomedicine Tumor Targeting
Targeted Anti‐Tumor Immunotherapy Using Tumor Infiltrating Cells
Tumor‐derived microparticles in tumor immunology and immunotherapy
Basic characterization of antibodies targeting receptors of the tumor necrosis factor receptor superfamily
Polyoxazoline‐Based Nanovaccine Synergizes with Tumor‐Associated Macrophage Targeting and Anti‐PD‐1 Immunotherapy against Solid Tumors
Targeting and repolarizing M2-like tumor-associated macrophage-mediated MR imaging and tumor immunotherapy by biomimetic nanoparticles
Emerging biomaterials for tumor immunotherapy
Toward integrative cancer immunotherapy: targeting the tumor microenvironment
Targeting PCSK9 to upregulate MHC-II on the surface of tumor cells in tumor immunotherapy
Targeting the macrophage immunocheckpoint: a novel insight into solid tumor immunotherapy
Emerging strategies in targeting tumor-resident myeloid cells for cancer immunotherapy
Nanomedicine Tumor Targeting
Nanomedicine Tumor Targeting
Targeted Anti‐Tumor Immunotherapy Using Tumor Infiltrating Cells
Tumor‐derived microparticles in tumor immunology and immunotherapy
Basic characterization of antibodies targeting receptors of the tumor necrosis factor receptor superfamily
Polyoxazoline‐Based Nanovaccine Synergizes with Tumor‐Associated Macrophage Targeting and Anti‐PD‐1 Immunotherapy against Solid Tumors
Targeting and repolarizing M2-like tumor-associated macrophage-mediated MR imaging and tumor immunotherapy by biomimetic nanoparticles
Emerging biomaterials for tumor immunotherapy
Toward integrative cancer immunotherapy: targeting the tumor microenvironment
Targeting PCSK9 to upregulate MHC-II on the surface of tumor cells in tumor immunotherapy
Targeting the macrophage immunocheckpoint: a novel insight into solid tumor immunotherapy
Emerging strategies in targeting tumor-resident myeloid cells for cancer immunotherapy
Nanomedicine Tumor Targeting
Nanomedicine Tumor Targeting
Targeted Anti‐Tumor Immunotherapy Using Tumor Infiltrating Cells
Tumor‐derived microparticles in tumor immunology and immunotherapy
Basic characterization of antibodies targeting receptors of the tumor necrosis factor receptor superfamily
Polyoxazoline‐Based Nanovaccine Synergizes with Tumor‐Associated Macrophage Targeting and Anti‐PD‐1 Immunotherapy against Solid Tumors
Targeting and repolarizing M2-like tumor-associated macrophage-mediated MR imaging and tumor immunotherapy by biomimetic nanoparticles